Symposium:
108. HIV State-of-the-Art
Friday, October 9, 2015: 8:30 AM-10:00 AM
Room: 6--AB

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • determine the most appropriate antiretroviral therapy regimens for first lien and subsequent therapies in the lifelong management of HIV infection in adults in the current era
  • discuss changing trends in the epidemiology of the HIV epidemic
  • evaluate new and novel approaches to facilitate adherence to lifelong antiretroviral therapy

Target Audience: Researchers, Pharmacists, Public health practitioners, Nurses, Infectious diseases physicians, Infectious diseases pediatricians, Infection preventionists, HIV specialists, HIV clinicians, Fellows, Epidemiologists, Clinicians, Academicians

Tracks: HIV-STD-TB, Global ID, Epidemiology and Infection Control, Adult ID

Moderators:  Constance Benson, MD, FIDSA, University of California, San Diego and Vincent Marconi, MD, FIDSA, Emory University School of Medicine

Presentations:
8:30 AM
666
Antiretroviral Therapy: Current and Future Options
Eric S. Daar, MD

9:00 AM
667
Global Trends in HIV Epidemiology
John T. Brooks, MD

9:30 AM
668
Optimizing Adherence to Antiretroviral Therapy: Current and Future Options
Carlos Del Rio, MD, FIDSA

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-15-168-L02-P

Disclosures:

C. Benson, None

V. Marconi, None

See more of: Symposium
<< Previous Session | Next Session >>

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.